Therapeutic potential of carbon monoxide in multiple sclerosis

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Carbon monoxide (CO) is a product of haem catabolism by haem oxygenase (HO) enzymes.
• Physiological roles of CO include vasodilation, neurotransmission, and anti-inflammatory actions.
• Exogenous CO administration shows promise for treating immune dysregulation.

Purpose of the Study:

• To review the physiological and anti-inflammatory roles of the HO/CO pathway in the central nervous system (CNS).
• To discuss the therapeutic potential of carbon monoxide-releasing molecules (CORMs) in preclinical models of inflammation.
• To evaluate CORMs as a potential disease-modifying therapy for multiple sclerosis.

Main Methods:

• Literature review of studies on the HO/CO pathway and CORMs.
• Analysis of preclinical data on CORM efficacy in inflammatory models.
• Synthesis of evidence regarding CORMs' impact on CNS inflammation.

Main Results:

• The HO/CO pathway plays significant physiological and anti-inflammatory roles within the CNS.
• CORMs effectively deliver controlled CO quantities, demonstrating anti-inflammatory effects in preclinical settings.
• Preclinical data suggest CORMs possess disease-modifying potential.

Conclusions:

• CORMs represent a promising class of compounds for managing CNS inflammation.
• The therapeutic application of CORMs in multiple sclerosis warrants further investigation.
• Targeting the HO/CO pathway with CORMs may offer novel treatment strategies.